Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.
about
Role of cues and contexts on drug-seeking behaviourTargeting the noradrenergic system for gender-sensitive medication development for tobacco dependencePharmacological treatment of comorbid PTSD and substance use disorder: recent progressCocaine increases dopaminergic neuron and motor activity via midbrain α1 adrenergic signaling.Tobacco addiction and the dysregulation of brain stress systems.Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seekingInvolvement of noradrenergic transmission in the PVN on CREB activation, TORC1 levels, and pituitary-adrenal axis activity during morphine withdrawalNicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.Effect of prazosin and guanfacine on stress-induced reinstatement of alcohol and food seeking in rats.AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking.Restraint stress attenuates nicotine's locomotor stimulant but not discriminative stimulus effects in rats.Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.A translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessationStimulation of α2-adrenergic receptors in the central nucleus of the amygdala attenuates stress-induced reinstatement of nicotine seeking in rats.Dopamine D3 receptors in the basolateral amygdala and the lateral habenula modulate cue-induced reinstatement of nicotine seeking.AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacologyThe selective anandamide transport inhibitor VDM11 attenuates reinstatement of nicotine seeking behaviour, but does not affect nicotine intakeEffects of prazosin, an α1-adrenergic receptor antagonist, on the seeking and intake of alcohol and sucrose in alcohol-preferring (P) rats.Nicotine-taking and nicotine-seeking in C57Bl/6J mice without prior operant training or food restrictionLow-dose prazosin alone and in combination with propranolol or naltrexone: effects on ethanol and sucrose seeking and self-administration in the P rat.α-1 Adrenergic receptors are localized on presynaptic elements in the nucleus accumbens and regulate mesolimbic dopamine transmission.Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.Emerging role for corticotropin releasing factor signaling in the bed nucleus of the stria terminalis at the intersection of stress and reward.Regulation of neurological and neuropsychiatric phenotypes by locus coeruleus-derived galanin.Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used.The Sensory Impact of Nicotine on Noradrenergic and Dopaminergic Neurons of the Nicotine Reward - Addiction Neurocircuitry.Effects of blockade of α4β2 and α7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats.Elevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humansEffect of doxazosin on stress reactivity and the ability to resist smoking.Extinction bursts in rats trained to self-administer nicotine or food in 1-h daily sessions.Electrical stimulation of the insular region attenuates nicotine-taking and nicotine-seeking behaviors.Effects of disulfiram on choice behavior in a rodent gambling task: association with catecholamine levels.
P2860
Q26825476-BE701D49-6C5C-49F5-8419-A9DF79AF63B8Q26999258-DF4832AB-7771-4D80-8B10-C1844C58535DQ27022219-E82AAE74-9463-48CF-8336-81BA964A0957Q27311149-98EDB41E-7F07-4CC7-9153-DC3517E761C1Q28111988-DE932F1C-F24D-4657-9C80-181DEB3A8804Q28480387-5406EB5C-78F3-40D7-896E-9AE6C7AA3F5AQ28480798-DF0B0539-9CE6-4ADA-92A5-7429F82F6A88Q30244252-43D59D7C-0779-4146-A91D-CD5D0DAAA02BQ30461991-4EDAA351-2D88-45F9-9631-54DF4825543DQ33759649-777052E3-045F-4D31-A332-E44F1308512CQ34115735-898C60EF-4D52-4E49-8114-257981D33145Q34407185-70A6A348-AF1B-4887-9AF7-71D0DDC7C63FQ34454236-32F1565F-D2DB-4B12-B906-3C1CF5E7827AQ34459334-B657CF39-34AD-436A-A627-D0C7520B8AAAQ34499327-4940AC62-C0F7-4025-A71A-7F25AE973058Q35223957-69A4485F-7627-4A49-82F2-926ABEEF32FAQ35593066-2F174846-E8DF-49CE-ABD1-D036D99CEB31Q35670393-3B507679-29AD-4D73-92A8-51F5E12B6B1DQ35846351-AF3BB9B6-AC76-4339-ACE6-D049F442B4AAQ35858582-7B9D923A-F5F1-4C83-BB4F-A4980EFD8460Q36100281-5550FA2B-3752-4A3F-9E65-0CE9C91C22D1Q36252777-4547A789-56BC-4F0E-A2B0-815EB1D7E358Q36881952-5FAB2EB9-A156-43F5-ACB0-627FE917423BQ36922331-95CE89FB-8D7E-4B0D-BE78-28547EC7AE8DQ37000172-47D44F3E-1B2E-42B0-A8F6-15C3CB18D2B5Q37028098-D991C9F9-341A-4F82-A2CC-25C260FE9EABQ37351302-4FB172B6-13C5-4FE1-B38A-FC3D73684619Q37409589-1CA54151-58C3-4AEF-A585-BC0581FD60C9Q40229079-79A56D63-BDEF-4609-A975-4C95699497F3Q41349799-A57BB873-4749-41BD-AA6C-DF3C5AC82A89Q43247605-9EA142DF-8B23-47CA-A024-001A8D667E36Q47585471-BD0E9F2C-34CB-4B79-B29C-9A30CB13B43C
P2860
Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.
@ast
Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.
@en
Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.
@nl
type
label
Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.
@ast
Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.
@en
Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.
@nl
prefLabel
Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.
@ast
Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.
@en
Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.
@nl
P2093
P2860
P356
P1476
Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.
@en
P2093
Abhiram Pushparaj
Benoit Forget
Bernard Le Foll
Carrie Wertheim
Paola Mascia
Steven R Goldberg
P2860
P2888
P304
P356
10.1038/NPP.2010.42
P407
P577
2010-03-31T00:00:00Z
P5875
P6179
1043688164